SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,815.00    120.00 (1.79%)
Bid:
6,820.00
Ask:
6,830.00
Spread: 10.00 (0.147%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading Update

18 Nov 2020 07:00

RNS Number : 6502F
Spirax-Sarco Engineering PLC
18 November 2020
 

 

News Release

 

Wednesday 18th November 2020

TRADING UPDATE

Resilient trading in line with expectations; full year expectations unchanged

 

Thermal energy management and niche pumping specialist, Spirax‐Sarco Engineering plc, issues the following trading update in respect of the four months ended 31st October 2020.

 

Economic environment

As anticipated, the global macro-economic environment improved during the third quarter of the year. Compared with the same period of 2019, global Industrial Production (IP)1 was down 4% in the third quarter, a strong improvement on the 12% contraction in the second quarter. Following robust sequential month-on-month IP growth in June and July, the rate of growth slowed markedly in August and September as industrial activity began to approach pre-pandemic levels.

 

Trading

Despite the challenging economic environment, trading has continued to hold up well. All production facilities remain open and operating without capacity constraints. Our sales engineers remain in close contact with our customers globally, with physical access to customers' facilities improving in those regions that are not subject to new lockdown measures.

 

Consistent with expectations shared at the Half Year results announcement in August, the organic sales decline in the four months to the end of October was less pronounced than in the first half of the year, supported by the recovery of global IP. Overall, the rate at which reported sales declined was marginally less than in the first half of the year, when reported sales benefited from the inclusion of Thermocoax which joined the Group in May 2019.

 

In the Steam Specialties business, organic sales in the four months to October declined less than in the first half of the year as the contraction in IP lessened across all regions and China returned to IP growth.

 

In the Electric Thermal Solutions business, organic sales in the four months to October also declined at a lower rate than in the first half of the year, as a similar organic sales decline in Chromalox was mitigated by strong organic sales growth in Thermocoax.

 

In the Watson-Marlow Fluid Technology Group, organic sales growth was higher in the four months to October compared with the first half of the year, as sales to the Biopharmaceutical sector remained strong and sales to the other industrial sectors recovered in line with global IP. Watson‐Marlow's exposure to the Biopharmaceutical and Medical Device markets makes it more resilient to the impact of COVID‐19, with many customers working on vaccine development and preparing for mass vaccine production.

 

The Group operating profit margin was higher in the four months to the end of October than in the first half of the year, supported by increased sales and continued cost containment actions. In the ten months to the end of October, the Group operating profit margin remained slightly below the same period in the prior year.

 

Currency effects continued to have an adverse impact on sales and operating profit, compared to the same period of 2019, as sterling maintained its strength against our basket of trade currencies. If spot rates at 31st October 2020 prevail for the remainder of the year, the headwind effect on full year sales and profit would be 2% and 4% respectively.

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. Excluding leases, our net borrowings at 31st October 2020 were £254 million, down from £326 million on 30th June 2020. The interim dividend of 33.5p per share was paid on 6th November at a cash cost of £25 million.

 

People

We continue to recognise and appreciate the individual and collective efforts of our 7,800 employees across nearly 70 countries that have allowed us to meet the needs of our customers. We have maintained a strong focus on the health and wellbeing of our employees and, thankfully, the rate of infection amongst our employees remains very low.

As previously announced, Neil Daws, Managing Director Steam Specialties and Executive Director will retire from the Steam Specialties business and the Board on 31st December 2020 after more than 42 years of service. We would again like to thank Neil for his huge contribution to the Group.

We are pleased to announce that Neil's successor, Maurizio Preziosa, will take over as Managing Director Steam Specialties from 1st January 2021 and become a member of the Group Executive Committee. Maurizio will be based at the Group Headquarters in Cheltenham, UK. Maurizio joined the Group in November 2011 as General Manager for Spirax-Sarco Italy, progressing to the role of Regional General Manager for Southern Europe in 2014, before becoming Divisional Director for Gestra in May 2017 where he led the successful integration and growth of the Gestra acquisition.

 

Also as previously announced, Angela Archon and Olivia Qiu will join the Board as Independent Non-Executive Directors effective 1st December 2020.

 

Outlook

After reaching a low point in the second quarter when global IP contracted 12%, macro-economic conditions improved in the third quarter with a global IP contraction of 4%. IP is now forecast to contract by an overall 5.5% in 2020. However, the sequential month-on-month rate of IP growth slowed markedly in August and September, infection rates remain high in the Americas and increasing levels in Europe are resulting in further lockdowns. Although the impact on IP growth in the fourth quarter resulting from the COVID-19 resurgence remains uncertain, these factors could further slow the rate of IP recovery in the final quarter of 2020, as we anticipated at the Half Year results announcement in August.

 

Sales and adjusted operating profit in the four months to the end of October were in line with our expectations at the time of our Half Year results. Therefore, absent a significant global IP deterioration in the remaining months of 2020, our overall expectations for the full year remain unchanged.

 

Spirax-Sarco Engineering plc expects to publish its preliminary 2020 results on 10th March 2021.

 

 

1 Source for industrial production data: Oxford Economics, 6th November 2020.

 

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Nimesh Patel, Chief Financial Officer

Shaun Laubscher, Head of Investor Relations

Tel: 01242 535234

 

Note: Operating profit refers to adjusted operating profit and organic performance measures are expressed at constant currency, excluding contributions from acquisitions and disposals as explained in Note 2 to the Consolidated Financial Statements for the period ended 30th June 2020.

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow Fluid Technology Group provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 7,800 people, of whom close to 1,800 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

Further information can be found at www.spiraxsarcoengineering.com

 RNS filter: Inside information prior to release

 

LEI 213800WFVZQMHOZP2W17

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKOBQDBDBDDD
Date   Source Headline
20th Nov 20085:11 pmRNSTransaction in Own Shares
19th Nov 20085:28 pmRNSTransaction in Own Shares
18th Nov 20085:27 pmRNSTransaction in Own Shares
17th Nov 20085:16 pmRNSTransaction in Own Shares
14th Nov 20085:07 pmRNSTransaction in Own Shares
13th Nov 20085:26 pmRNSTransaction in Own Shares
12th Nov 20085:10 pmRNSTransaction in Own Shares
11th Nov 20085:19 pmRNSTransaction in Own Shares
10th Nov 20085:17 pmRNSTransaction in Own Shares
10th Nov 20082:12 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSInterim Management Statement
5th Nov 20085:22 pmRNSHolding(s) in Company
4th Nov 20089:56 amRNSAcquisition
3rd Nov 20082:54 pmRNSTotal Voting Rights
7th Oct 20089:24 amRNSDirector/PDMR Shareholding
1st Oct 20089:38 amRNSTotal Voting Rights
30th Sep 200810:52 amRNSDirector/PDMR Shareholding
1st Sep 20082:36 pmRNSTotal Voting Rights
27th Aug 20087:00 amRNS2008 Half Year Results
11th Aug 200812:36 pmRNSNotice of Results
8th Aug 20083:15 pmRNSHolding(s) in Company
1st Aug 20083:55 pmRNSTotal Voting Rights
2nd Jul 20082:10 pmRNSTotal Voting Rights
18th Jun 200811:55 amRNSHolding(s) in Company
16th Jun 200812:21 pmRNSHolding(s) in Company
9th Jun 20084:45 pmRNSHolding(s) in Company
4th Jun 20082:33 pmRNSNotification of Major Interes
2nd Jun 20089:00 amRNSTotal Voting Rights
21st May 20084:12 pmRNSDirector/PDMR Shareholding
15th May 20083:54 pmRNSHolding(s) in Company
15th May 20083:37 pmRNSHolding(s) in Company
13th May 200812:00 pmRNSInterim Management Statement
13th May 200812:00 pmRNSInterim Management Statement
1st May 200810:03 amRNSTotal Voting Rights
1st Apr 200810:32 amRNSTotal Voting Rights
12th Mar 20084:55 pmRNSDirector/PDMR Shareholding
11th Mar 200812:11 pmRNSDirector/PDMR Shareholding
10th Mar 20087:01 amRNSFinal Results
3rd Mar 20089:09 amRNSTotal Voting Rights
3rd Mar 20088:54 amRNSAcquisition
27th Feb 20083:49 pmRNSNotice of Results
1st Feb 20081:41 pmRNSTotal Voting Rights
1st Feb 20081:39 pmRNSAcquisition
4th Jan 20089:57 amRNSTotal Voting Rights
20th Dec 20075:02 pmRNSDirector/PDMR Shareholding
20th Dec 20074:58 pmRNSDirector/PDMR Shareholding
13th Dec 200710:23 amRNSBoard Changes
3rd Dec 200711:39 amRNSTotal Voting Rights
16th Nov 20075:41 pmRNSHolding(s) in Company
12th Nov 20073:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.